tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market
ANNX
Annexon Biosciences
RESEARCH TOOLSreports
Want to see ANNX full AI Analyst Report?

Annexon Biosciences (ANNX) Income Statement

1,401 Followers

Annexon Biosciences Income Statement

Last quarter (Q4 2025), Annexon Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Annexon Biosciences's net income was $-48.26M. See Annexon Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.69M$ -3.45M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 212.72M$ 150.62M$ 143.72M$ 145.60M$ 130.71M
Depreciation and Amortization
$ 2.65M$ 3.45M$ 2.15M$ 2.15M$ 2.14M
EBITDA
$ -213.76M$ -134.75M$ -141.57M$ -143.45M$ -128.57M
Operating Income
$ -216.41M$ -154.07M$ -143.72M$ -145.60M$ -130.71M
Other Income/Expenses
$ 9.72M$ 15.87M$ 9.49M$ 3.65M$ 390.00K
Pretax Income
$ -206.69M$ -138.20M$ -134.24M$ -141.95M$ -130.32M
Net Income
$ -206.69M$ -138.20M$ -134.24M$ -141.95M$ -130.32M
Per Share Metrics
Basic EPS
$ -1.34$ -1.01$ -1.77$ -2.60$ -3.34
Diluted EPS
$ -1.34$ -1.01$ -1.77$ -2.60$ -3.34
Weighted Average Shares Outstanding
 155.11M 137.40M 75.67M 54.67M 38.32M
Weighted Average Shares Outstanding (Diluted)
 155.11M 137.40M 75.67M 54.67M 38.32M
Currency in USD

Annexon Biosciences Earnings and Revenue History